Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Genocea Biosciences (GNCA) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 28 quarters since 2014. Compare with GNCA stock chart to see long term trends.

GNCA stock compared to

GNCA Income Statement

Revenue, Net:null
Research & Development Expense:7838000
Total Operating Expenses:11714000
Operating Income:-11714000
Net Income:-11960000
Earnings Per Share, Basic:-0.05
Shares Outstanding, Basic Avg:44436000

GNCA Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-9642000
Net Cash from Financing Activities:3153000
Property, Plant & Equipment Purchases:1371000
Net Cash from Investing Activities:-1367000
Net Change in Cash & Equivalents:-7856000

GNCA Balance Sheet

Cash and Cash Equivalents:80400000
Total Current Assets:82227000
Property, Plant & Equipment, Net:5123000
Total Assets:98493000
Accounts Payable:534000
Current Portion of Long-Term Debt:13862000
Total Short-Term Liabilities:24995000
Long Term Debt, Non-Current Portion:0
Total Liabilities:89511000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
BVF Inc Il
4,012,404 sh
1,994,006 sh
99%
$9,188
$4,546
Vanguard Group Inc
1,618,686 sh
834,718 sh
106%
$3,707
$1,904
Boxer Capital, LLC
1,134,453 sh
1,134,453 sh
NEW
$2,598
$2,598
Kingdon Capital Management, L.L.C.
711,552 sh
 
$1,629
Sabby Management, LLC
312,666 sh
187,354 sh
150%
$716
$428
Bank Of America Corp /De/
283,902 sh
277,676 sh
4460%
$650
$636
Renaissance Technologies LLC
210,694 sh
95,323 sh
83%
$482
$217
Blackrock Inc.
135,067 sh
-59,994 sh
-31%
$309
-$139
Northern Trust Corp
37,313 sh
-6,326 sh
-14%
$85
-$15
Morgan Stanley
2,108 sh
-2,534 sh
-55%
$5
-$5
Alyeska Investment Group, L.P.
Call options for 0 sh
-1,196,981 sh
-100%
$0
-$2,753
Virtu Financial LLC
0 sh
-36,686 sh
-100%
$0
-$84
Proequities, Inc.
0 sh
 
$0

Data imported from Genocea Biosciences Inc SEC filings. Check original filings before making any investment decision.